NCT01657682
- Conditions
- Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies
Explore clinical trials studying Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies